{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:05:32Z","timestamp":1790247932085,"version":"4.1.0"},"reference-count":223,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"European Commission Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.pharmr.2026.100149","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:27:17Z","timestamp":1782491237000},"page":"100149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronic pain in Alzheimer disease and the role of neuroimmune interactions"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4296-5727","authenticated-orcid":false,"given":"Marzia","family":"Malcangio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Sideris-Lampretsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pharmr.2026.100149_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"issue":"7121","key":"10.1016\/j.pharmr.2026.100149_bib2","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature05413","article-title":"An SCN9A channelopathy causes congenital inability to experience pain","volume":"444","author":"Cox","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/bmb\/ldaa003","article-title":"Understanding the genetic basis of congenital insensitivity to pain","volume":"133","author":"Drissi","year":"2020","journal-title":"Br Med Bull"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib4","article-title":"Pain in dementia","volume":"5","author":"Achterberg","year":"2020","journal-title":"Pain Rep"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100149_bib5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1152\/physrev.00025.2008","article-title":"Models and mechanisms of hyperalgesia and allodynia","volume":"89","author":"Sandkuhler","year":"2009","journal-title":"Physiol Rev"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib6","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.mayocp.2015.01.018","article-title":"Neuropathic pain: principles of diagnosis and treatment","volume":"90","author":"Gilron","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"10289","key":"10.1016\/j.pharmr.2026.100149_bib7","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","article-title":"Chronic pain: an update on burden, best practices, and new advances","volume":"397","author":"Cohen","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1152\/physrev.00045.2019","article-title":"Neuropathic pain: from mechanisms to treatment","volume":"101","author":"Finnerup","year":"2021","journal-title":"Physiol Rev"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100149_bib9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrrheum.2014.64","article-title":"Mechanisms, impact and management of pain in rheumatoid arthritis","volume":"10","author":"Walsh","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100149_bib10","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1097\/j.pain.0000000000002324","article-title":"Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system","volume":"162","author":"Kosek","year":"2021","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100149_bib11","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1097\/j.pain.0000000000002323","article-title":"Nociplastic pain: helping to explain disconnect between pain and pathology","volume":"162","author":"Walsh","year":"2021","journal-title":"Pain"},{"issue":"10289","key":"10.1016\/j.pharmr.2026.100149_bib12","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","article-title":"Nociplastic pain: towards an understanding of prevalent pain conditions","volume":"397","author":"Fitzcharles","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100149_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010364","article-title":"Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies","volume":"6","author":"Fayaz","year":"2016","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12916-016-0619-1","article-title":"Contact heat sensitivity and reports of unpleasantness in communicative people with mild to moderate cognitive impairment in Alzheimer's disease: a cross-sectional study","volume":"14","author":"Monroe","year":"2016","journal-title":"BMC Med"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100149_bib15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrneurol.2012.53","article-title":"Assessment and treatment of pain in people with dementia","volume":"8","author":"Corbett","year":"2012","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100149_bib16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/hsc.12204","article-title":"Exploring the prevalence of and factors associated with pain: a cross-sectional study of community-dwelling people with dementia","volume":"24","author":"Barry","year":"2016","journal-title":"Health Soc Care Community"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100149_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012546","article-title":"Association of comorbidity and health service usage among patients with dementia in the UK: a population-based study","volume":"7","author":"Browne","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.pharmr.2026.100149_bib18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/WAD.0b013e3181630b5c","article-title":"The relationship between different pain assessments in dementia","volume":"22","author":"Cohen-Mansfield","year":"2008","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-016-0295-1","article-title":"Pain treatment for nursing home residents differs according to cognitive state \u2013 a cross-sectional study","volume":"16","author":"Bauer","year":"2016","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.pharmr.2026.100149_bib20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.pnpbp.2019.04.006","article-title":"The silent epidemic of chronic pain in older adults","volume":"93","author":"Domenichiello","year":"2019","journal-title":"Prog Neuro-Psychopharmacology Biol Psychiatry"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100149_bib21","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1001\/jamainternmed.2017.1622","article-title":"Association between persistent pain and memory decline and dementia in a longitudinal cohort of elders","volume":"177","author":"Whitlock","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"10284","key":"10.1016\/j.pharmr.2026.100149_bib22","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib23","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1474-4422(18)30490-3","article-title":"The role of astroglia in Alzheimer\u2019s disease: pathophysiology and clinical implications","volume":"18","author":"Arranz","year":"2019","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100149_bib25","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.immuni.2019.12.003","article-title":"Microglia, lifestyle stress, and neurodegeneration","volume":"52","author":"Madore","year":"2020","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100149_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"6450","key":"10.1016\/j.pharmr.2026.100149_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav9518","article-title":"Amyloid \u03b2 oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes","volume":"365","author":"Nortley","year":"2019","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100149_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","article-title":"Staging of Alzheimer\u2019s disease-related neurofibrillary changes","volume":"16","author":"Braak","year":"1995","journal-title":"Neurobiol Aging"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100149_bib30","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-017-0184-x","article-title":"Late onset Alzheimer\u2019s disease genetics implicates microglial pathways in disease risk","volume":"12","author":"Efthymiou","year":"2017","journal-title":"Mol Neurodegener"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100149_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","article-title":"Neuroinflammation in Alzheimer disease","volume":"25","author":"Heneka","year":"2025","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100149_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","article-title":"Sex differences in Alzheimer disease \u2014 the gateway to precision medicine","volume":"14","author":"Ferretti","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib34","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights on the genetic etiology of Alzheimer\u2019s and related dementia","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-28473-8","article-title":"Single-cell RNA sequencing reveals time- and sex-specific responses of mouse spinal cord microglia to peripheral nerve injury and links ApoE to chronic pain","volume":"13","author":"Tansley","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100149_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41583-025-00914-5","article-title":"How microglia contribute to the induction and maintenance of neuropathic pain","volume":"26","author":"Malcangio","year":"2025","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmr.2026.100149_bib37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.bbi.2021.06.005","article-title":"Microglial heterogeneity in chronic pain","volume":"96","author":"Sideris-Lampretsas","year":"2021","journal-title":"Brain Behav Immun"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100149_bib38","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41583-019-0218-1","article-title":"Astrocytes in chronic pain and itch","volume":"20","author":"Ji","year":"2019","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s12276-023-01148-0","article-title":"Pathological phenotypes of astrocytes in Alzheimer's disease","volume":"56","author":"Kim","year":"2024","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.pharmr.2026.100149_bib40","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2147\/CIA.S36739","article-title":"Pain management in patients with dementia","volume":"8","author":"Achterberg","year":"2013","journal-title":"Clin Interv Aging"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib41","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/j.pain.0000000000002111","article-title":"Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease","volume":"162","author":"Lawn","year":"2020","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100149_bib42","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40263-016-0342-7","article-title":"Identifying and managing pain in people with Alzheimer\u2019s disease and other types of dementia: a systematic review","volume":"30","author":"Husebo","year":"2016","journal-title":"CNS Drugs"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100149_bib43","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0885-3924(95)00121-2","article-title":"Pain in cognitively impaired nursing home patients","volume":"10","author":"Ferrell","year":"1995","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib44","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.3233\/JAD-150808","article-title":"Pain assessment in elderly with behavioral and psychological symptoms of dementia","volume":"50","author":"Malara","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100149_bib45","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jamda.2016.12.078","article-title":"Prevalence of pain in nursing home residents: the role of dementia stage and dementia subtypes","volume":"18","author":"van Kooten","year":"2017","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib46","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/j.pain.0000000000000095","article-title":"Pain, agitation, and behavioural problems in people with dementia admitted to general hospital wards: a longitudinal cohort study","volume":"156","author":"Sampson","year":"2015","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100149_bib47","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jpainsymman.2004.04.012","article-title":"Pain in community-dwelling persons with dementia: frequency, intensity, and congruence between patient and caregiver report","volume":"28","author":"Shega","year":"2004","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100149_bib48","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jamda.2014.12.016","article-title":"From admission to death: prevalence and course of pain, agitation, and shortness of breath, and treatment of these symptoms in nursing home residents with dementia","volume":"16","author":"Hendriks","year":"2015","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100149_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2017.01.024","article-title":"Epidemiology of pain in people with dementia living in care homes: longitudinal course, prevalence, and treatment implications","volume":"18","author":"Rajkumar","year":"2017","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.pharmr.2026.100149_bib50","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3389\/fphar.2019.01699","article-title":"Sensing technology to facilitate behavioral and psychological symptoms and to monitor treatment response in people with dementia: a systematic review","volume":"10","author":"Husebo","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.JAM.0000043422.31640.F7","article-title":"Development and psychometric evaluation of the pain assessment in advanced dementia (PAINAD) scale","volume":"4","author":"Warden","year":"2003","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib52","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jamda.2011.04.002","article-title":"Which score most likely represents pain on the observational PAINAD pain scale for patients with dementia?","volume":"13","author":"Zwakhalen","year":"2012","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib53","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jphys.2017.07.003","article-title":"Mobilization-observation-behaviour-intensity-dementia-2 pain scale (MOBID-2)","volume":"63","author":"Husebo","year":"2017","journal-title":"J Physiother"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.12968\/ijpn.2004.10.1.12013","article-title":"The Abbey pain scale: a 1-minute numerical indicator for people with end-stage dementia","volume":"10","author":"Abbey","year":"2004","journal-title":"Int J Palliat Nurs"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100149_bib55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1567205016666181212162424","article-title":"The temporal relationship between pain intensity and pain interference and incident dementia","volume":"16","author":"Ezzati","year":"2019","journal-title":"Curr Alzheimer Res"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100149_bib56","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.joca.2019.05.021","article-title":"Association of osteoarthritis and pain with Alzheimer\u2019s diseases and related dementias among older adults in the United States","volume":"27","author":"Ikram","year":"2019","journal-title":"Osteoarthr Cartil"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100149_bib57","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1177\/07334648241237340","article-title":"Chronic non-cancer pain and associated risks of incident mild cognitive impairment and Alzheimer\u2019s disease and related dementias in middle-aged and older adults","volume":"43","author":"Hu","year":"2024","journal-title":"J Appl Gerontol"},{"key":"10.1016\/j.pharmr.2026.100149_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1193108","article-title":"Chronic pain is a risk factor for incident Alzheimer\u2019s disease: a nationwide propensity-matched cohort using administrative data","volume":"15","author":"Bornier","year":"2023","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib59","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0304-3959(98)00228-0","article-title":"Pain threshold and tolerance in Alzheimer\u2019s disease","volume":"80","author":"Benedetti","year":"1999","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100149_bib60","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1155\/2001\/814374","article-title":"An examination of pain perception and cerebral event-related potentials following carbon dioxide laser stimulation in patients with Alzheimer\u2019s disease and age-matched control volunteers","volume":"6","author":"Gibson","year":"2001","journal-title":"Pain Res Manag"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100149_bib61","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1093\/brain\/awl228","article-title":"Pain sensitivity and fMRI pain-related brain activity in Alzheimer\u2019s disease","volume":"129","author":"Cole","year":"2006","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100149_bib62","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.pain.2013.12.031","article-title":"Quantitative sensory testing and pain tolerance in patients with mild to moderate Alzheimer disease compared to healthy control subjects","volume":"155","author":"Jensen-Dahm","year":"2014","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib63","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pain.2007.09.007","article-title":"The facial expression of pain in patients with dementia","volume":"133","author":"Kunz","year":"2007","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100149_bib64","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ejpain.2008.05.001","article-title":"Influence of dementia on multiple components of pain","volume":"13","author":"Kunz","year":"2009","journal-title":"Eur J Pain"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100149_bib65","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/AJP.0000000000000302","article-title":"Effects of Alzheimer disease on the facial expression of pain","volume":"32","author":"Beach","year":"2016","journal-title":"Clin J Pain"},{"key":"10.1016\/j.pharmr.2026.100149_bib66","article-title":"The impact of Alzheimer\u2019s disease on the functional connectivity between brain regions underlying pain perception","volume":"15","author":"Cole","year":"2011","journal-title":"Eur J Pain"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib67","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/pm\/pnv012","article-title":"Contact heat evoked potentials (CHEPs) in patients with mild-moderate Alzheimer\u2019s disease and matched control\u2014A pilot study","volume":"17","author":"Jensen-Dahm","year":"2016","journal-title":"Pain Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib68","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pain.2004.05.015","article-title":"Pain reactivity in Alzheimer patients with different degrees of cognitive impairment and brain electrical activity deterioration","volume":"111","author":"Benedetti","year":"2004","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib69","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pain.2005.12.016","article-title":"Loss of expectation-related mechanisms in Alzheimer\u2019s disease makes analgesic therapies less effective","volume":"121","author":"Benedetti","year":"2006","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100149_bib70","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1172\/JCI42843","article-title":"Nociceptors: the sensors of the pain pathway","volume":"120","author":"Dubin","year":"2010","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib71","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuron.2020.10.027","article-title":"Mechanical allodynia circuitry in the dorsal horn is defined by the nature of the injury","volume":"109","author":"Peirs","year":"2021","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100149_bib72","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nrn2947","article-title":"Neuronal circuitry for pain processing in the dorsal horn","volume":"11","author":"Todd","year":"2010","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100149_bib73","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/35053509","article-title":"The molecular dynamics of pain control","volume":"2","author":"Hunt","year":"2001","journal-title":"Nat Rev Neurosci"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100149_bib74","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1113\/JP274165","article-title":"The plasticity of descending controls in pain: translational probing","volume":"595","author":"Bannister","year":"2017","journal-title":"J Physiol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100149_bib75","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4103\/1673-5374.250567","article-title":"The hypothalamic-spinal dopaminergic system: a target for pain modulation","volume":"14","author":"Puopolo","year":"2019","journal-title":"Neural Regen Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100149_bib76","first-page":"447","article-title":"The 'in's and out's' of descending pain modulation from the rostral ventromedial medulla","volume":"47","author":"De Preter","year":"2024","journal-title":"Trends Neurosci"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100149_bib77","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm.2235","article-title":"Nociceptor sensitization in pain pathogenesis","volume":"16","author":"Gold","year":"2010","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100149_bib78","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/ar3305","article-title":"Update on peripheral mechanisms of pain: beyond prostaglandins and cytokines","volume":"13","author":"Schaible","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100149_bib79","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.neuron.2007.07.016","article-title":"Nociceptors\u2014Noxious stimulus detectors","volume":"55","author":"Woolf","year":"2007","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib80","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00221-009-1808-3","article-title":"Differential effects of TRPV channel block on polymodal activation of rat cutaneous nociceptors in vitro","volume":"196","author":"St. Pierre","year":"2009","journal-title":"Exp Brain Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib81","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00221-009-1814-5","article-title":"Excitation and sensitization of nociceptors by bradykinin: what do we know?","volume":"196","author":"Mizumura","year":"2009","journal-title":"Exp Brain Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib82","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1749-6632.2009.05301.x","article-title":"The role of proinflammatory cytokines in the generation and maintenance of joint pain","volume":"1193","author":"Schaible","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100149_bib83","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nm.1976","article-title":"Hematopoietic colony\u2013stimulating factors mediate tumor-nerve interactions and bone cancer pain","volume":"15","author":"Schweizerhof","year":"2009","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib84","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00221-009-1755-z","article-title":"Mode of action of cytokines on nociceptive neurons","volume":"196","author":"\u00dc\u00e7eyler","year":"2009","journal-title":"Exp Brain Res"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100149_bib85","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.tins.2003.09.017","article-title":"Central sensitization and LTP: do pain and memory share similar mechanisms?","volume":"26","author":"Ji","year":"2003","journal-title":"Trends Neurosci"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100149_bib86","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1523\/JNEUROSCI.10-08-02717.1990","article-title":"Dynamic alterations in the cutaneous mechanoreceptive fields of dorsal horn neurons in the rat spinal cord","volume":"10","author":"Woolf","year":"1990","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100149_bib87","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/SPC.0000000000000207","article-title":"What do monoamines do in pain modulation?","volume":"10","author":"Bannister","year":"2016","journal-title":"Curr Opin Support Palliat Care"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100149_bib88","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","article-title":"Neuroinflammation and central sensitization in chronic and widespread pain","volume":"129","author":"Ji","year":"2018","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100149_bib89","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neuron.2020.11.007","article-title":"Shaping neuronal fate: functional heterogeneity of direct microglia-neuron interactions","volume":"109","author":"Cser\u00e9p","year":"2020","journal-title":"Neuron"},{"issue":"1\u20133","key":"10.1016\/j.pharmr.2026.100149_bib90","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejphar.2013.03.023","article-title":"Astrocytes--multitaskers in chronic pain","volume":"716","author":"Hansen","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100149_bib91","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.neuron.2018.11.009","article-title":"Microglia in pain: detrimental and protective roles in pathogenesis and resolution of pain","volume":"100","author":"Chen","year":"2018","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100149_bib92","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nrn.2018.2","article-title":"Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential","volume":"19","author":"Inoue","year":"2018","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib93","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/sjpain-2019-0138","article-title":"Role of the immune system in neuropathic pain","volume":"20","author":"Malcangio","year":"2019","journal-title":"Scand J Pain"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib94","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuron.2009.09.033","article-title":"Current challenges in glia-pain biology","volume":"64","author":"McMahon","year":"2009","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib95","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1038\/s41467-023-39077-1","article-title":"Galectin-3 activates spinal microglia to induce inflammatory nociception in wild type but not in mice modelling Alzheimer\u2019s disease","volume":"14","author":"Sideris-Lampretsas","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib96","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nn.4189","article-title":"Injured sensory neuron\u2013derived CSF1 induces microglial proliferation and DAP12-dependent pain","volume":"19","author":"Guan","year":"2016","journal-title":"Nat Neurosci"},{"issue":"7070","key":"10.1016\/j.pharmr.2026.100149_bib97","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nature04223","article-title":"BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain","volume":"438","author":"Coull","year":"2005","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib98","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1471-4159.2010.06837.x","article-title":"Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice","volume":"114","author":"Staniland","year":"2010","journal-title":"J Neurochem"},{"issue":"25","key":"10.1016\/j.pharmr.2026.100149_bib99","doi-asserted-by":"crossref","first-page":"10655","DOI":"10.1073\/pnas.0610811104","article-title":"Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain","volume":"104","author":"Clark","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100149_bib100","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1523\/JNEUROSCI.0828-09.2009","article-title":"The liberation of fractalkine in the dorsal horn requires microglial cathepsin S","volume":"29","author":"Clark","year":"2009","journal-title":"J Neurosci"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100149_bib101","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.pain.2014.06.007","article-title":"Spinal HMGB1 induces TLR4-mediated long-lasting hypersensitivity and glial activation and regulates pain-like behavior in experimental arthritis","volume":"155","author":"Agalave","year":"2014","journal-title":"Pain"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100149_bib102","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.pain.2011.09.020","article-title":"Spinal TLR4 mediates the transition to a persistent mechanical hypersensitivity after the resolution of inflammation in serum-transferred arthritis","volume":"152","author":"Christianson","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.pharmr.2026.100149_bib103","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1097\/j.pain.0000000000001306","article-title":"Targeting toll-like receptor-4 (TLR4)-an emerging therapeutic target for persistent pain states","volume":"159","author":"Bruno","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.pharmr.2026.100149_bib104","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cophys.2019.03.008","article-title":"Supraspinal neuroimmune crosstalk in chronic pain states","volume":"11","author":"Austin","year":"2019","journal-title":"Curr Opin Physiol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100149_bib105","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/jnr.23883","article-title":"Topography of microglial activation in sensory- and affect-related brain regions in chronic pain","volume":"95","author":"Taylor","year":"2017","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharmr.2026.100149_bib106","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neuroscience.2019.08.005","article-title":"Peripheral nerve injury triggers neuroinflammation in the medial prefrontal cortex and ventral hippocampus in a subgroup of rats with coincident affective behavioural changes","volume":"416","author":"Fiore","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmr.2026.100149_bib107","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fnins.2019.00213","article-title":"Brain microglial activation in chronic pain-associated affective disorder","volume":"13","author":"Barcelon","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.pharmr.2026.100149_bib108","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916646784","article-title":"Interleukin-1\u03b2 overproduction is a common cause for neuropathic pain, memory deficit, and depression following peripheral nerve injury in rodents","volume":"12","author":"Gui","year":"2016","journal-title":"Mol Pain"},{"key":"10.1016\/j.pharmr.2026.100149_bib109","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3389\/fnins.2017.00209","article-title":"Spared nerve injury increases the expression of microglia M1 markers in the prefrontal cortex of rats and provokes depression-like behaviors","volume":"11","author":"Xu","year":"2017","journal-title":"Front Neurosci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100149_bib110","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/brain\/awu377","article-title":"Evidence for brain glial activation in chronic pain patients","volume":"138","author":"Loggia","year":"2015","journal-title":"Brain"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100149_bib111","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/glia.21056","article-title":"Spinal injection of TNF-\u03b1-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1","volume":"58","author":"Gao","year":"2010","journal-title":"Glia"},{"issue":"42","key":"10.1016\/j.pharmr.2026.100149_bib112","doi-asserted-by":"crossref","first-page":"10482","DOI":"10.1523\/JNEUROSCI.3593-08.2008","article-title":"Supraspinal glial\u2013neuronal interactions contribute to descending pain facilitation","volume":"28","author":"Wei","year":"2008","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100149_bib113","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.expneurol.2011.11.006","article-title":"Propentofylline, a CNS glial modulator does not decrease pain in post-herpetic neuralgia patients: in vitro evidence for differential responses in human and rodent microglia and macrophages","volume":"234","author":"Landry","year":"2012","journal-title":"Exp Neurol"},{"issue":"11S","key":"10.1016\/j.pharmr.2026.100149_bib114","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1097\/j.pain.0000000000003342","article-title":"\"Neuroinflammation\": does it have a role in chronic pain? Evidence from human imaging","volume":"165","author":"Loggia","year":"2024","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib115","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/art.42013","article-title":"Dynamic functional connectivity underlying temporal summation of pain in fibromyalgia","volume":"74","author":"Cheng","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib116","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1042\/BST20150058","article-title":"The methodology of TSPO imaging with positron emission tomography","volume":"43","author":"Turkheimer","year":"2015","journal-title":"Biochem Soc Trans"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100149_bib117","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.semnuclmed.2024.09.007","article-title":"Emerging TSPO-PET radiotracers for imaging neuroinflammation: a critical analysis","volume":"54","author":"Cumbers","year":"2024","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.pharmr.2026.100149_bib118","first-page":"157","article-title":"Cytokines in cerebrospinal fluid and chronic pain in humans: past, present, and future","volume":"31","author":"Rosenstr\u00f6m","year":"2024","journal-title":"Neuroimmunomodulation"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100149_bib119","doi-asserted-by":"crossref","DOI":"10.21037\/atm-22-5319","article-title":"The Danish Pain Research Biobank (DANPAIN-Biobank): a collection of blood, cerebrospinal fluid, and clinical data for the study of neuroimmune and glia-related biomarkers of chronic pain","volume":"11","author":"Blichfeldt-Eckhardt","year":"2023","journal-title":"Ann Transl Med"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100149_bib120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.brainresrev.2009.11.004","article-title":"Neuroglia in neurodegeneration","volume":"63","author":"Heneka","year":"2010","journal-title":"Brain Res Rev"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib121","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.devcel.2015.01.022","article-title":"Cellular functions of the amyloid precursor protein from development to dementia","volume":"32","author":"van der Kant","year":"2015","journal-title":"Dev Cell"},{"key":"10.1016\/j.pharmr.2026.100149_bib122","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1749-6632.1992.tb27476.x","article-title":"Secretion of the beta-amyloid precursor protein","volume":"674","author":"Sisodia","year":"1992","journal-title":"Ann N Y Acad Sci"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100149_bib123","doi-asserted-by":"crossref","first-page":"8336","DOI":"10.1523\/JNEUROSCI.0540-14.2014","article-title":"CNS amyloid-beta, soluble APP-alpha and -beta kinetics during BACE inhibition","volume":"34","author":"Dobrowolska","year":"2014","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib124","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100149_bib126","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","article-title":"Roles of tau protein in health and disease","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib127","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2020.01.027","article-title":"Posttranslational modifications mediate the structural diversity of tauopathy strains","volume":"180","author":"Arakhamia","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib128","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol Neurodegener"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100149_bib129","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1474-4422(03)00556-8","article-title":"Pain processing in dementia and its relation to neuropathology","volume":"2","author":"Scherder","year":"2003","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100149_bib130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3233\/JAD-121864","article-title":"The distribution of phosphorylated tau in spinal cords of Alzheimer\u2019s disease and non-demented individuals","volume":"34","author":"Dugger","year":"2013","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.pharmr.2026.100149_bib131","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2147\/NDT.S90735","article-title":"Detection of hyperphosphorylated tau protein and \u03b1-synuclein in spinal cord of patients with Alzheimer\u2019s disease","volume":"12","author":"Wang","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100149_bib132","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/jnen\/60.11.1075","article-title":"Spinal cord neurofibrillary pathology in Alzheimer disease and Guam Parkinsonism-dementia complex","volume":"60","author":"Schmidt","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib133","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00004691-199701000-00002","article-title":"Neuroanatomy of the pain system and of the pathways that modulate pain","volume":"14","author":"Willis","year":"1997","journal-title":"J Clin Neurophysiol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib134","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0891-0618(02)00007-8","article-title":"The intralaminar nuclei assigned to the medial pain system and other components of this system are early and progressively affected by the Alzheimer\u2019s disease-related cytoskeletal pathology","volume":"23","author":"R\u00fcb","year":"2002","journal-title":"J Chem Neuroanat"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100149_bib135","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/brain\/awv404","article-title":"Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer\u2019s disease","volume":"139","author":"Rodriguez-Vieitez","year":"2016","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100149_bib136","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s004010000320","article-title":"The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer\u2019s disease-related cytoskeletal pathology","volume":"101","author":"R\u00fcb","year":"2001","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100149_bib137","doi-asserted-by":"crossref","first-page":"823","DOI":"10.18632\/aging.101195","article-title":"Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degeneration","volume":"9","author":"Andr\u00e9s-Benito","year":"2017","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib138","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12974-019-1608-z","article-title":"The link between chronic pain and Alzheimer\u2019s disease","volume":"16","author":"Cao","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib139","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40478-017-0411-2","article-title":"Locus coeruleus cellular and molecular pathology during the progression of Alzheimer\u2019s disease","volume":"5","author":"Kelly","year":"2017","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib140","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41392-023-01628-9","article-title":"Astrocytes in human central nervous system diseases: a frontier for new therapies","volume":"8","author":"Verkhratsky","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib141","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.nurt.2010.05.017","article-title":"Astrocytes in Alzheimer's disease","volume":"7","author":"Verkhratsky","year":"2010","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib142","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nm838","article-title":"Adult mouse astrocytes degrade amyloid-\u03b2 in vitro and in situ","volume":"9","author":"Wyss-Coray","year":"2003","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100149_bib143","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1058","article-title":"Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-\u03b2 peptides","volume":"10","author":"Koistinaho","year":"2004","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib144","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/0192623310385254","article-title":"Role of astrocytes in brain function and disease","volume":"39","author":"Sidoryk-Wegrzynowicz","year":"2011","journal-title":"Toxicol Pathol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100149_bib145","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/s41593-020-00735-y","article-title":"Severe reactive astrocytes precipitate pathological hallmarks of Alzheimer's disease via excessive H2O2-production","volume":"23","author":"Chun","year":"2020","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib146","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","article-title":"Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse","volume":"89","author":"Zhang","year":"2016","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib147","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s13311-014-0316-8","article-title":"The evolving biology of microglia in Alzheimer's disease","volume":"12","author":"Malm","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100149_bib148","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/s41591-025-03574-1","article-title":"Microglial mechanisms drive amyloid-\u03b2 clearance in immunized patients with Alzheimer\u2019s disease","volume":"31","author":"van Olst","year":"2025","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100149_bib149","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in Alzheimer's disease","volume":"16","author":"Heneka","year":"2015","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100149_bib150","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41583-018-0057-5","article-title":"Microglial signatures and their role in health and disease","volume":"19","author":"Butovsky","year":"2018","journal-title":"Nat Rev Neurosci"},{"issue":"37","key":"10.1016\/j.pharmr.2026.100149_bib151","doi-asserted-by":"crossref","first-page":"12538","DOI":"10.1523\/JNEUROSCI.0853-14.2014","article-title":"Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway","volume":"34","author":"Lee","year":"2014","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100149_bib152","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/j.pain.0000000000000644","article-title":"Reduced thermal sensitivity and increased opioidergic tone in the TASTPM mouse model of Alzheimer\u2019s disease","volume":"157","author":"Aman","year":"2016","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib153","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbr.2006.11.044","article-title":"Non-cognitive behaviours in an APP\/PS1 transgenic model of Alzheimer's disease","volume":"178","author":"Pugh","year":"2007","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib154","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ejp.1288","article-title":"Impaired chronic pain-like behaviour and altered opioidergic system in the TASTPM mouse model of Alzheimer\u2019s disease","volume":"23","author":"Aman","year":"2019","journal-title":"Eur J Pain"},{"key":"10.1016\/j.pharmr.2026.100149_bib155","article-title":"CD206+\/MHCII\u2212 macrophage accumulation at nerve injury site correlates with attenuation of allodynia in TASTPM mouse model of Alzheimer\u2019s disease","volume":"26","author":"Silva","year":"2022","journal-title":"Brain Behav Immun Health"},{"key":"10.1016\/j.pharmr.2026.100149_bib156","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuroscience.2013.06.064","article-title":"Reduced expression of pain mediators and pain sensitivity in amyloid precursor protein over-expressing CRND8 transgenic mice","volume":"250","author":"Shukla","year":"2013","journal-title":"Neuroscience"},{"issue":"46","key":"10.1016\/j.pharmr.2026.100149_bib157","doi-asserted-by":"crossref","first-page":"18175","DOI":"10.1523\/JNEUROSCI.4933-12.2013","article-title":"Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies","volume":"33","author":"Mellone","year":"2013","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib158","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/NEN.0000000000000176","article-title":"Neuroinflammatory signals in Alzheimer disease and APP\/PS1 transgenic mice","volume":"74","author":"L\u00f3pez-Gonz\u00e1lez","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100149_bib159","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021050","article-title":"P301S Mutant human tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gating","volume":"6","author":"Takeuchi","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100149_bib160","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular A\u03b2 and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2026.100149_bib161","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2015.06.007","article-title":"Tail-flick test response in 3\u00d7Tg-AD mice at early and advanced stages of disease","volume":"600","author":"Baeta-Corral","year":"2015","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib162","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","article-title":"Regulation of tau pathology by the microglial fractalkine receptor","volume":"68","author":"Bhaskar","year":"2010","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib163","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrn.2016.7","article-title":"TREM2 variants: new keys to decipher Alzheimer disease pathogenesis","volume":"17","author":"Colonna","year":"2016","journal-title":"Nat Rev Neurosci"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100149_bib164","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41577-018-0051-1","article-title":"Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight","volume":"18","author":"Shi","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100149_bib165","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/1533317513495107","article-title":"Elevated galectin-3 levels in the serum of patients with Alzheimer's disease","volume":"30","author":"Wang","year":"2015","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib166","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1326-9-20","article-title":"Altered microglial response to A\u03b2 plaques in APPPS1-21 mice heterozygous for TREM2","volume":"9","author":"Ulrich","year":"2014","journal-title":"Mol Neurodegener"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100149_bib167","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1084\/jem.20171529","article-title":"Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism","volume":"215","author":"Song","year":"2018","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100149_bib168","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41593-018-0296-9","article-title":"Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE","volume":"22","author":"Parhizkar","year":"2019","journal-title":"Nat Neurosci"},{"issue":"43","key":"10.1016\/j.pharmr.2026.100149_bib169","doi-asserted-by":"crossref","first-page":"11524","DOI":"10.1073\/pnas.1710311114","article-title":"TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy","volume":"114","author":"Leyns","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7761","key":"10.1016\/j.pharmr.2026.100149_bib170","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","article-title":"Single-cell transcriptomic analysis of Alzheimer\u2019s disease","volume":"570","author":"Mathys","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100149_bib171","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00401-021-02263-w","article-title":"Distinct amyloid-\u03b2 and tau-associated microglia profiles in Alzheimer\u2019s disease","volume":"141","author":"Gerrits","year":"2021","journal-title":"Acta Neuropathol"},{"issue":"6286","key":"10.1016\/j.pharmr.2026.100149_bib172","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100149_bib173","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrn.2016.141","article-title":"Network abnormalities and interneuron dysfunction in Alzheimer disease","volume":"17","author":"Palop","year":"2016","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib174","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.26804","article-title":"Association of chronic pain with biomarkers of neurodegeneration, microglial activation, and inflammation in cerebrospinal fluid and impaired cognitive function","volume":"95","author":"Sadlon","year":"2024","journal-title":"Ann Neurol"},{"issue":"7489","key":"10.1016\/j.pharmr.2026.100149_bib175","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/bmj.330.7489.461","article-title":"Recent developments in pain in dementia","volume":"330","author":"Scherder","year":"2005","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100149_bib176","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jalz.2014.06.013","article-title":"Frequent use of opioids in patients with dementia and nursing home residents: a study of the entire elderly population of Denmark","volume":"11","author":"Jensen-Dahm","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100149_bib177","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/pds.1600","article-title":"The use of central nervous system drugs and analgesics among very old people with and without dementia","volume":"17","author":"L\u00f6vheim","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib178","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0885-3924(00)00113-5","article-title":"A comparison of pain and its treatment in advanced dementia and cognitively intact patients with hip fracture","volume":"19","author":"Morrison","year":"2000","journal-title":"J Pain Symptom Manage"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100149_bib179","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1532-5415.1998.tb06644.x","article-title":"Treatment of pain in cognitively impaired compared with cognitively intact older patients with hip-fracture","volume":"46","author":"Feldt","year":"1998","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100149_bib180","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/14740338.2019.1614166","article-title":"Analgesic treatments in people with dementia - how safe are they? A systematic review","volume":"18","author":"Erdal","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.pharmr.2026.100149_bib181","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/j.pain.0000000000001430","article-title":"Pain assessment in advanced dementia","volume":"160","author":"Lukas","year":"2019","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100149_bib182","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/gps.906","article-title":"Opioid treatment for agitation in patients with advanced dementia","volume":"18","author":"Manfredi","year":"2003","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.pharmr.2026.100149_bib183","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4065","article-title":"Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial","volume":"343","author":"Husebo","year":"2011","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100149_bib184","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s40266-018-0546-2","article-title":"Efficacy and safety of analgesic treatment for depression in people with advanced dementia: randomised, multicentre, double-blind, placebo-controlled trial (DEP.PAIN.DEM)","volume":"35","author":"Erdal","year":"2018","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib185","first-page":"1","article-title":"Impact of prescribed opioid use on development of dementia among patients with chronic non-cancer pain","volume":"14","author":"Oh","year":"2024","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib186","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00228-018-02612-x","article-title":"Identifying potentially inappropriate prescribing in older people with dementia: a systematic review","volume":"75","author":"Hukins","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl 13","key":"10.1016\/j.pharmr.2026.100149_bib187","first-page":"S346","article-title":"Effective pharmacological management of Alzheimer's disease","volume":"17","author":"Atri","year":"2011","journal-title":"Am J Manag Care"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib188","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3233\/JAD-170045","article-title":"Mouse models of Alzheimer\u2019s disease","volume":"57","author":"Esquerda-Canals","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmr.2026.100149_bib189","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.807473","article-title":"Recent advances in the modeling of Alzheimer's disease","volume":"16","author":"Sasaguri","year":"2022","journal-title":"Front Neurosci"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100149_bib190","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainres.2004.05.029","article-title":"Cognitive correlates of A\u03b2 deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes","volume":"1017","author":"Howlett","year":"2004","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib191","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41467-024-45729-7","article-title":"The secondary somatosensory cortex gates mechanical and heat sensitivity","volume":"15","author":"Taub","year":"2024","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib192","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/bmc.1130010405","article-title":"Opioid peptides in the cerebrospinal fluid of Alzheimer patients","volume":"1","author":"Muhlbauer","year":"1986","journal-title":"Biomed Chromatogr"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100149_bib193","doi-asserted-by":"crossref","first-page":"21562","DOI":"10.1074\/jbc.M100710200","article-title":"Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695","volume":"276","author":"Chishti","year":"2001","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib194","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12868-018-0446-8","article-title":"Cognitive and emotional alterations in App knock-in mouse models of A\u03b2 amyloidosis","volume":"19","author":"Sakakibara","year":"2018","journal-title":"BMC Neurosci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100149_bib195","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2026.100149_bib196","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.expneurol.2014.07.008","article-title":"Selective impact of Tau loss on nociceptive primary afferents and pain sensation","volume":"261","author":"Sotiropoulos","year":"2014","journal-title":"Exp Neurol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100149_bib197","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00401-022-02469-6","article-title":"Galectin-3 is elevated in CSF and is associated with A\u03b2 deposits and tau aggregates in brain tissue in Alzheimer\u2019s disease","volume":"144","author":"Boza-Serrano","year":"2022","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pharmr.2026.100149_bib198","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fnins.2018.00430","article-title":"Investigation of Gal-3 expression pattern in serum and cerebrospinal fluid of patients suffering from neurodegenerative disorders","volume":"12","author":"Ashraf","year":"2018","journal-title":"Front Neurosci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib199","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s13760-020-01477-1","article-title":"Evaluation of serum galectin-3 levels at Alzheimer patients by stages: a preliminary report","volume":"121","author":"Yazar","year":"2021","journal-title":"Acta Neurol Belg"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100149_bib200","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100149_bib201","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.neuron.2021.01.027","article-title":"White matter aging drives microglial diversity","volume":"109","author":"Safaiyan","year":"2021","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib202","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40478-015-0203-5","article-title":"Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis","volume":"3","author":"Holtman","year":"2015","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100149_bib203","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00401-019-02013-z","article-title":"Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer\u2019s disease","volume":"138","author":"Boza-Serrano","year":"2019","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100149_bib204","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","article-title":"Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation","volume":"26","author":"Johnson","year":"2020","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib205","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41418-019-0348-z","article-title":"Galectin-3 promotes A\u03b2 oligomerization and A\u03b2 toxicity in a mouse model of Alzheimer\u2019s disease","volume":"27","author":"Tao","year":"2020","journal-title":"Cell Death Differ"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100149_bib206","doi-asserted-by":"crossref","DOI":"10.1172\/JCI165523","article-title":"Galectin-3 aggravates microglial activation and tau transmission in tauopathy","volume":"134","author":"Siew","year":"2024","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100149_bib207","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.celrep.2015.02.012","article-title":"Microglia-secreted galectin-3 acts as a toll-like receptor 4 ligand and contributes to microglial activation","volume":"10","author":"Burguillos","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.pharmr.2026.100149_bib208","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbi.2024.01.002","article-title":"Injured sensory neurons-derived galectin-3 contributes to neuropathic pain via programming microglia in the spinal dorsal horn","volume":"117","author":"Shan","year":"2024","journal-title":"Brain Behav Immun"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100149_bib209","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.pain.2011.11.022","article-title":"Contribution of spinal galectin-3 to acute herpetic allodynia in mice","volume":"153","author":"Takasaki","year":"2012","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100149_bib210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148792","article-title":"Galectin-3 inhibition is associated with neuropathic pain attenuation after peripheral nerve injury","volume":"11","author":"Ma","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2026.100149_bib211","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2015.06.025","article-title":"Galectin-3 and post-myocardial infarction cardiac remodeling","volume":"763","author":"Meijers","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100149_bib212","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cca.2014.01.019","article-title":"Galectin-3 in cancer","volume":"431","author":"Song","year":"2014","journal-title":"Clinica Chimica Acta"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib213","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1002\/med.21784","article-title":"Microglia-derived galectin-3 in neuroinflammation; a bittersweet ligand?","volume":"41","author":"Rahimian","year":"2021","journal-title":"Med Res Rev"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100149_bib214","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.tips.2023.06.001","article-title":"Targeting galectin-3 in inflammatory and fibrotic diseases","volume":"44","author":"Bouffette","year":"2023","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib215","article-title":"Contribution of colony-stimulating factor 1 to neuropathic pain","volume":"6","author":"Yu","year":"2021","journal-title":"Pain Rep"},{"key":"10.1016\/j.pharmr.2026.100149_bib216","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.3389\/fimmu.2019.03061","article-title":"Neuraxial cytokines in pain states","volume":"10","author":"Gon\u00e7alves Dos Santos","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100149_bib217","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pharmrev.121.000400","article-title":"Targeting systemic innate immune cells as a therapeutic avenue for Alzheimer disease","volume":"74","author":"Pons","year":"2022","journal-title":"Pharmacol Rev"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100149_bib218","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1091\/mbc.e06-10-0975","article-title":"Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils","volume":"18","author":"Majumdar","year":"2007","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmr.2026.100149_bib219","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2018.01.015","article-title":"Mendelian adult-onset leukodystrophy genes in Alzheimer's disease: critical influence of CSF1R and NOTCH3","volume":"66","author":"Sassi","year":"2018","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100149_bib220","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/brain\/awv379","article-title":"Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology","volume":"139","author":"Olmos-Alonso","year":"2016","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100149_bib221","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1093\/brain\/awz241","article-title":"CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice","volume":"142","author":"Mancuso","year":"2019","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100149_bib222","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/bpa.12483","article-title":"Inflammasome activation and innate immunity in Alzheimer's disease","volume":"27","author":"Heneka","year":"2017","journal-title":"Brain Pathol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100149_bib223","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archneur.65.8.1091","article-title":"Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer\u2019s research consortium study","volume":"65","author":"O\u2019Bryant","year":"2008","journal-title":"Arch Neurol"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:24:48Z","timestamp":1790245488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699726000372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":223,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0031699726000372"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100149","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic pain in Alzheimer disease and the role of neuroimmune interactions","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100149"}}